Literature DB >> 18305914

[Zoledronic acid for preventing fractures. HORIZON trial (Health Outcomes and Reduced Incidence with Zoledronic acid ONce yearly)].

J D Ringe1, S Nitschmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18305914     DOI： 10.1007/s00108-008-2067-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  1 in total

1.  Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

Authors:  Ian R Reid; Paul Miller; Kenneth Lyles; William Fraser; Jacques P Brown; Youssef Saidi; Peter Mesenbrink; Guoqin Su; Judy Pak; Ken Zelenakas; Monica Luchi; Peter Richardson; David Hosking
Journal:  N Engl J Med       Date:  2005-09-01       Impact factor: 91.245
  1 in total
  1 in total

1.  [Zoledronic acid for preventing fractures].

Authors:  V Traut
Journal:  Internist (Berl)       Date:  2008-08       Impact factor: 0.743
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.